The FDA has granted Fast Track designation to 2 investigational combination vaccines to prevent influenza and COVID-19 infections in adults 50 years and older.
Stanford scientists have developed a prototype for a topical vaccine, which may remove the need for injections. They modified a specific bacterium with the tetanus toxin’s gene fragment. Then, ...